Combination of nitrous oxide and lidocaine to prevent withdrawal after rocuronium in children

Hyun-Jeong Kwak1, Yun Jeong Chae, Sook Young Lee

  • 1Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea.

Insights

Pretreating pediatric patients with nitrous oxide and lidocaine significantly reduces painful withdrawal responses to rocuronium injection. This combination therapy offers a safer anesthesia experience for children undergoing procedures.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Pain on injection is a frequent adverse event associated with rocuronium administration in pediatric patients.
  • Effective pain management strategies are crucial for improving pediatric patient comfort during anesthesia induction.

Purpose of the Study:

  • To evaluate the efficacy of combined nitrous oxide and lidocaine pretreatment in mitigating withdrawal responses to rocuronium injection in children.
  • To compare the incidence of withdrawal movements between a nitrous oxide/lidocaine group and an oxygen/lidocaine group.

Main Methods:

  • A prospective, randomized, double-blind study involving 66 pediatric patients (ages 5-12 years).
  • Patients received either 100% oxygen or 50% nitrous oxide in oxygen.
  • Anesthesia was induced with thiopental, followed by forearm occlusion, lidocaine injection, and subsequent rocuronium injection, with responses graded on a 4-point scale.

Main Results:

  • The incidence of withdrawal movements was significantly lower in the nitrous oxide group (3.1%) compared to the oxygen group (25.8%) (P = 0.013).
  • No patients in the nitrous oxide group exhibited severe withdrawal movements (grade 3 or 4).

Conclusions:

  • Inhaled 50% nitrous oxide combined with lidocaine pretreatment effectively reduces rocuronium-induced withdrawal movements in pediatric patients.
  • This combination therapy represents a significant improvement over lidocaine pretreatment alone for managing injection pain in children.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...